Cost-effectiveness of vaccination of immunocompetent older adults against herpes zoster in the Netherlands: a comparison between the adjuvanted subunit and live-attenuated vaccines | BMC Medicine | Full Text

Cost-effectiveness of vaccination of immunocompetent older adults against herpes zoster in the Netherlands: a comparison between the adjuvanted subunit and live-attenuated vaccines | BMC Medicine | Full Text

Research: Cost-effectiveness of Herpes vaccination

A Markov model on the cost-effectiveness of Herpes Zoster (HZ) vaccinations indicates that a strategy with two doses of HZ/su was superior in reducing the burden of HZ as compared to a single dose or single dose + booster of ZVL